Major reinsurers look to emerging markets with underinsured risk
Reinsurers, such as Hannover Re, Munich Re and Swiss Re are looking to new, underinsured markets, such as cyber risk, to provide opportunities for growth.  Cyber insurance is expected to triple to $7.5bn in annual premiums by 2020, says a new report, and some of the reinsurers say that closing the huge protection gap, by making more natural disasters insurable, may help to stabilise price levels.  Furthermore, some experts see a risk of greater losses from natural catastrophes, following several benign years, with natural disasters in emerging markets tending to be under-insured, thereby providing a good growth opportunity.
The FINANCIAL — Accenture is launching the Accenture Intelligent Patient Platform, a suite of integrated cloud-based, analytics-driven technologies designed to deliver real-time, actionable insights on patient care across the entire patient experience.

ADVERTISEMENT

The Accenture Intelligent Patient Platform helps life sciences companies provide patients with comprehensive, outcome-driven patient services such as program enrollment, adherence management and treatment education over the full course of treatment for an illness or disease. It allows companies to rapidly deploy precise patient services based on the requirements of unique patient segments by providing an integrated set of capabilities across patient engagement and patient data management, including connected devices, apps and analytics, according to Accenture.



The Accenture Intelligent Patient Platform is designed to evolve with the addition of new applications aimed at delivering supplementary services to meet patients’ changing needs. The new platform will enable life sciences companies to quantify the impact of their patient programs across all modes of engagement, such as in-person and digital, so they can refine program effectiveness and continuously improve the patient experience.

The Accenture Intelligent Patient Platform provides several business benefits to life sciences companies, their customers, and their patients.

Patients can start a therapy faster and easily get the help they need to manage their condition;

Providers can receive increased support in their patient care goals of quality, affordability and engagement;

Payers can more rapidly get the information they need for reimbursement; and

Pharmacies can get the correct information they need to fill prescriptions eliminating unnecessary follow-ups with physicians and patients.

“The Accenture Intelligent Patient Platform is playing an important role helping life sciences companies deploy their patient engagement strategies and facilitate better patient interactions and outcomes,” said Tony Romito, managing director, Accenture Life Sciences. “Now companies can have real-time insight into the full patient journey and work across the healthcare system to effect meaningful change in support of the patient.”



“The Accenture Intelligent Patient Platform is the result of the close working relationship between Salesforce and Accenture,” said Kori O’Brien, vice president, global alliances and industry solutions, Salesforce. “We believe this Fullforce Solution will empower customers in the life sciences industry to connect with, care for and engage patients in meaningful new ways.”



The Accenture Intelligent Patient Platform, part of the Accenture Intelligent Patient Solutions and is comprised of an integrated set of evidence-based services supporting the full patient journey from pre-diagnosis through ongoing treatment to help life sciences clients deliver improved patient and economic outcomes. These services utilize unique population health analytics and proprietary patient technology to redefine how companies incorporate the patient into the development, launch and support of their innovative science. Click here to learn more about the Accenture Intelligent Patient Platform.